Month: September 2022

Festi hf.: Guðrún Aðalsteinsdóttir to be the new CEO of Krónan ehf.

Written by Customer Service on September 27, 2022. Posted in Public Companies.

Guðrún Aðalsteinsdóttir, engineer, has been appointed as Krónan’s managing director. She will assume the position as of today, 27 September, 2022. She succeeds Ásta Sigríður Fjeldsted, who was appointed CEO of Festi, Krónan’s parent company, on 7 September. Guðrún has worked at Krónan for almost two years, most recently as director of digital development and improvement projects, and before that as director of procurement and product management. Guðrún is an operational engineer with an M.Sc. from the Technical University of Denmark (DTU). She previously worked as a director at Icelandair in the operations department, where she was responsible for, among other things, sales and service of the company’s aircraft, product development, purchasing, inventory management and related production. She also has international experience...

Karolinska Development’s portfolio company Modus Therapeutics has completed recruitment in a clinical phase 1b study of sevuparin

Written by Customer Service on September 27, 2022. Posted in Public Companies.

STOCKHOLM, SWEDEN September 27, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Modus Therapeutics has completed the recruitment in a clinical phase 1b study of sevuparin, where the company’s lead asset sevuparin is being evaluated for the treatment of sepsis and septic shock. The randomized, placebo-controlled phase 1b study evaluates the effects of sevuparin in healthy volunteers after they have been induced with the bacterial toxin lipopolysaccharide (LPS), a provocation that is a well-established model for characterizing early stages of septic inflammation. The aim of the study is also to evaluate the safety profile of sevuparin when the substance is used in combination with heparin, a standard prophylactic, blood-thinning substance. “Modus Therapeutics’ drug candidate sevuparin has...

Foresight Solar & Technology VCT plc – Result of AGM

Written by Customer Service on September 27, 2022. Posted in Public Companies.

FORESIGHT SOLAR & TECHNOLOGY VCT PLC (“Company”)Legal Entity Identity number: 21380013CXOR8N6OD977AGM Statement The board of the Company (“Board”) is pleased to announce that at the Annual General Meeting of the Company held on 27 September 2022, all of the resolutions were passed on a unanimous show of hands. The voting was as follows:Resolution Votes For (including discretion) Votes Against1 – To receive the Annual Report and Accounts 2,355,749 45,0002 – To approve the Directors’ Remuneration Policy 2,279,790 104,5473 – To approve the Directors’ Remuneration Report 2,296,202 104,5474 – To re-elect Ernie Richardson as Director 2,342,282 50,2985 – To re-elect Timothy Dowlen as Director 2,313,847 63,9966 – To re-elect Carol Thompson as Director 2,316,760 50,2987 – To re-appoint Deloitte LLP as Auditor 2,312,851 61,6818...

SL Green Realty Corp. to Release Third Quarter 2022 Financial Results After Market Close on October 19, 2022

Written by Customer Service on September 27, 2022. Posted in Public Companies.

Conference Call to be Held on October 20, 2022 at 2:00 pm ET NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG), Manhattan’s largest office landlord, today announced that it will release its earnings for the third quarter of 2022 on Wednesday, October 19, 2022 after market close. The Company’s executive management team, led by Marc Holliday, Chairman and Chief Executive Officer, will host a conference call and audio webcast on Thursday, October 20, 2022 at 2:00 pm ET to discuss the financial results. Simultaneous with the earnings release, supplemental data will be made available in the Investors section of the SL Green Realty Corp. website at https://slgreen.com under “Financial Reports”. The live conference call will be webcast in listen-only mode and a replay will be available in the Investors...

Outlook Therapeutics® and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD

Written by Customer Service on September 27, 2022. Posted in Public Companies.

ISELIN, N.J. and CONSHOHOCKEN, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, and AmerisourceBergen (NYSE: ABC), a global healthcare company and leader in specialty pharmaceutical distribution and services, announced today that they have entered into a strategic relationship in preparation for the anticipated commercial launch in the United States of ONS-5010 / LYTENAVA™ (bevacizumab-vikg), if approved by the U.S. Food and Drug Administration (FDA). AmerisourceBergen will provide third-party logistics (3PL) services and distribution, as well as medical information and pharmacovigilance services in the United States. As Outlook Therapeutics...

Reklaim Signs Letter of Intent to Acquire Multimedia Lists Inc.

Written by Customer Service on September 27, 2022. Posted in Mergers And Acquisitions.

Multimedia Lists is cash flow positive and is expected to double Reklaim’s monthly revenue immediately upon the close of the transaction. NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Reklaim (OTCQB: MYIDF) (TSXV: MYID) (“Reklaim”), the destination for consumers to access and reclaim their data, announces it has entered into a non-binding letter of intent to purchase the assets of Multimedia Lists, Inc. (“MML”), a data broker currently operating in the United States (the “Transaction”). MML is a cash flow-positive company and is expected to immediately double the monthly revenue of Reklaim when the Transaction closes. The Transaction remains conditional on a number of customary factors, including, but not limited to, entering into a definitive agreement, final approval of the TSX Venture Exchange,...

Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Written by Customer Service on September 27, 2022. Posted in Mergers And Acquisitions.

Licensing Subset of Mindset’s Family 1 Intellectual Property Underscores Strength of Mindset’s Portfolio and Business Strategy TORONTO, Sept. 27, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset”), a drug discovery company developing novel, optimized, next-generation psychedelic and non-psychedelic medications to treat neuropsychiatric and neurological disorders with unmet medical needs, today announced an exclusive licensing agreement for Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) to acquire intellectual property rights for a subset of Mindset’s preclinical compounds (the “Agreement”). Under the terms of the Agreement, Cybin will license intellectual property related to preclinical compounds within Mindset’s “Family 1” portfolio, excluding MSP-1014, Mindset’s lead psychedelic drug candidate. “Over...

TransUnion Launches TruValidate Device Risk with Behavioral Analytics to Help Businesses Reduce Billions of Dollars in Fraud Losses from False Positives

Written by Customer Service on September 27, 2022. Posted in Public Companies.

Inclusion of NeuroID behavioral analytics helps provide immediate value during the application process CHICAGO, Sept. 27, 2022 (GLOBE NEWSWIRE) — To help limit the more than $100 billion1 of global sales revenue lost to false positives during the fraud detection process, TransUnion (NYSE: TRU) announced today the launch of TruValidate Device Risk with Behavioral Analytics. The solution is newly fortified by NeuroID’s behavioral analytics and aims to help businesses stop fraud – not good customers – based on device recognition, context, device and user behavior. The solution builds trusted connections by allowing users to join a global network of 6,000 fraud and security analysts, over 10 billion known devices and 100 million+ detailed known fraud reports. TransUnion’s TruValidate Device Risk with Behavioral Analytics is configurable,...

Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S.

Written by Customer Service on September 27, 2022. Posted in Public Companies.

CHICAGO and LOUGHBOROUGH, Sept. 27, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc.(NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces that it has entered into a preliminary agreement with EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry. The agreement covers the U.S. and all global sales and marketing of Nemaura’s Diabetes Management Solution, BEATdiabetes. The BEATdiabetes program is based on Nemaura’s noninvasive glucose monitoring solution, proBEAT. Nemaura and EVERSANA will work together to develop the optimal launch strategy for large-scale adoption of the diabetes management program, including franchising...

Teledyne introduces Contact Image Sensors for high-speed, high-resolution line scan imaging

Written by Customer Service on September 27, 2022. Posted in Public Companies.

Teledyne’s AxCIS Contact Image Sensor The new AxCIS is a high-speed, high-resolution line scan solution for space limited systemsWATERLOO, Ontario, Sept. 27, 2022 (GLOBE NEWSWIRE) — Teledyne DALSA is pleased to introduce AxCIS™, a new family of high-speed and high-resolution fully integrated line scan imaging modules. These easy-to-use Contact Image Sensors (CIS) combine sensors, lenses, and lights all-in-one, offering a lower cost inspection system for many demanding machine vision applications. AxCIS is powered by Teledyne’s new quadlinear CMOS image sensors, which deliver up to 120 kHz line rates for mono, 60 kHz x 3 for colour, at 900 dpi resolution, so that defects can be detected with unprecedented precision. Its unique staggered sensor design covers the whole field of view without missing pixels, providing a 100%...

Month: September 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals